Alterations in homologous recombination repair genes in prostate

The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment

Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer: Trends in Molecular Medicine

Frontiers Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors

The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies - Rimar - 2017 - Cancer - Wiley Online Library

PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations

Homologous Recombination Repair Deficiency: An Overview for Pathologists - Modern Pathology

Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications - Toh - 2021 - The Oncologist - Wiley Online Library

Prostate cancer and PARP inhibitors: progress and challenges, Journal of Hematology & Oncology

Homologous recombination deficiency (HRD)

Defective homologous recombination in human cancers - ScienceDirect

Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer

SPOP mutation leads to genomic instability in prostate cancer

Molecular Genetics of Prostate Cancer and Role of Genomic Testing - Surgical Pathology Clinics

Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer - European Urology Oncology